Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels

Mucosal Immunol. 2010 Mar;3(2):172-81. doi: 10.1038/mi.2009.129. Epub 2009 Dec 2.

Abstract

The gut mucosa is an important site of HIV immunopathogenesis with severe depletion of CD4+ T cells occurring during acute infection. The effect of prolonged anti-retroviral therapy (ART) on cycling and restoration of T lymphocytes in the gut remains unclear. Colon and terminal ileal biopsies and peripheral blood samples were collected from viremic, untreated, HIV-infected participants, patients treated with prolonged ART (>5 years), and uninfected controls and analyzed by flow cytometry. In the gut, the proportion of cycling T cells decreased and the number of CD4+ T cells normalized in treated patients in parallel with beta 7 expression on CD4+ T cells in blood. Cycling of gut T cells in viremic patients was associated with increased plasma LPS levels, but not colonic HIV-RNA. These data suggest that gut T-cell activation and microbial translocation may be interconnected whereas prolonged ART may decrease activation and restore gut CD4+ T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Anti-Retroviral Agents / pharmacology*
  • Anti-Retroviral Agents / therapeutic use*
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Cycle / immunology
  • Colon / immunology
  • Down-Regulation
  • Flow Cytometry
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • Humans
  • Ileum / immunology
  • Intestinal Mucosa / immunology*
  • Lipopolysaccharides / blood*
  • Middle Aged
  • Time Factors

Substances

  • Anti-Retroviral Agents
  • Lipopolysaccharides